Achieve Life Sciences (ACHV) Receivables - Net (2010 - 2021)

Achieve Life Sciences has disclosed Receivables - Net across 11 years of filings, most recently posting $200000.0 for Q3 2021.

• Quarterly Receivables - Net changed N/A year-over-year to $200000.0 in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $200000.0 (changed N/A YoY) and the FY2019 annual result came in at $8000.0, up 14.29% from the prior year.
• Receivables - Net climbed to $200000.0 in Q3 2021, from $8000.0 in the prior quarter.
• Over five years, Receivables - Net peaked at $241000.0 in Q2 2017 and troughed at $7000.0 in Q1 2018.
• A 4-year average of $92800.0 and a median of $47500.0 in 2017 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2017 — Receivables - Net plunged 98.12% — and 2019, when it increased 14.29%.
• Tracing ACHV's Receivables - Net over 4 years: stood at $9000.0 in 2017, then dropped by 22.22% to $7000.0 in 2018, then gained by 14.29% to $8000.0 in 2019, then soared by 2400.0% to $200000.0 in 2021.
• Business Quant data shows ACHV's Receivables - Net at $200000.0 in Q3 2021, $8000.0 in Q4 2019, and $7000.0 in Q4 2018.